RESUMO
Patients with coronary artery disease (CAD) are at high risk for reactivation of the varicella zoster virus (VZV) and development of herpes zoster (HZ). Here, we found that macrophages from patients with CAD actively suppress T cell activation and expansion, leading to defective VZV-specific T cell immunity. Monocyte-derived and plaque-infiltrating macrophages from patients with CAD spontaneously expressed high surface density of the immunoinhibitory ligand programmed death ligand-1 (PD-L1), thereby providing negative signals to programmed death-1+ (PD-1+) T cells. We determined that aberrant PD-L1 expression in patient-derived macrophages was metabolically controlled. Oversupply of the glycolytic intermediate pyruvate in mitochondria from CAD macrophages promoted expression of PD-L1 via induction of the bone morphogenetic protein 4/phosphorylated SMAD1/5/IFN regulatory factor 1 (BMP4/p-SMAD1/5/IRF1) signaling pathway. Thus, CAD macrophages respond to nutrient excess by activating the immunoinhibitory PD-1/PD-L1 checkpoint, leading to impaired T cell immunity. This finding indicates that metabolite-based immunotherapy may be a potential strategy for restoring adaptive immunity in CAD.
Assuntos
Antígeno B7-H1/metabolismo , Doença da Artéria Coronariana/metabolismo , Imunidade Celular , Ácido Pirúvico/metabolismo , Linfócitos T/imunologia , Idoso , Antígeno B7-H1/imunologia , Proteína Morfogenética Óssea 4/imunologia , Proteína Morfogenética Óssea 4/metabolismo , Doença da Artéria Coronariana/imunologia , Doença da Artéria Coronariana/patologia , Feminino , Humanos , Fator Regulador 1 de Interferon/imunologia , Fator Regulador 1 de Interferon/metabolismo , Macrófagos/imunologia , Macrófagos/metabolismo , Masculino , Pessoa de Meia-Idade , Receptor de Morte Celular Programada 1/imunologia , Receptor de Morte Celular Programada 1/metabolismo , Ácido Pirúvico/imunologia , Proteína Smad1/imunologia , Proteína Smad1/metabolismo , Proteína Smad5/imunologia , Proteína Smad5/metabolismo , Linfócitos T/metabolismo , Linfócitos T/patologiaRESUMO
Macrophages are responsible for the control of inflammation and healing, and their malfunction results in cardiometabolic disorders. TGF-ß is a pleiotropic growth factor with dual (protective and detrimental) roles in atherogenesis. We have previously shown that in human macrophages, TGF-ß1 activates Smad2/3 signaling and induces a complex gene expression program. However, activated genes were not limited to known Smad2/3-dependent ones, which prompted us to study TGF-ß1-induced signaling in macrophages in detail. Analysis of Id3 regulatory sequences revealed a novel enhancer, located between +4517 and 4662 bp, but the luciferase reporter assay demonstrated that this enhancer is not Smad2/3 dependent. Because Id3 expression is regulated by Smad1/5 in endothelial cells, we analyzed activation of Smad1/5 in macrophages. We demonstrate here for the first time, to our knowledge, that TGF-ß1, but not BMPs, activates Smad1/5 in macrophages. We show that an ALK5/ALK1 heterodimer is responsible for the induction of Smad1/5 signaling by TGF-ß1 in mature human macrophages. Activation of Smad1/5 by TGF-ß1 induces not only Id3, but also HAMP and PLAUR, which contribute to atherosclerotic plaque vulnerability. We suggest that the balance between Smad1/5- and Smad2/3-dependent signaling defines the outcome of the effect of TGF-ß on atherosclerosis where Smad1/5 is responsible for proatherogenic effects, whereas Smad2/3 regulate atheroprotective effects of TGF-ß.
Assuntos
Macrófagos/imunologia , Placa Aterosclerótica/imunologia , Transdução de Sinais/imunologia , Proteína Smad1/imunologia , Proteína Smad5/imunologia , Fator de Crescimento Transformador beta1/imunologia , Receptores de Activinas Tipo II/imunologia , Proteínas Morfogenéticas Ósseas/imunologia , Células Cultivadas , Hepcidinas/imunologia , Humanos , Proteínas Inibidoras de Diferenciação/imunologia , Macrófagos/patologia , Proteínas de Neoplasias/imunologia , Placa Aterosclerótica/patologia , Proteínas Serina-Treonina Quinases/imunologia , Receptor do Fator de Crescimento Transformador beta Tipo I , Receptores de Fatores de Crescimento Transformadores beta/imunologia , Receptores de Ativador de Plasminogênio Tipo Uroquinase/imunologia , Proteína Smad2/imunologia , Proteína Smad3/imunologiaRESUMO
Various members of the bone morphogenetic protein (BMP) family have been shown to regulate mammalian follicular development by affecting granulosa cell proliferation and steroidogenesis. In situ hybridization studies have shown expression of BMPR1A, BMPR1B, and BMPR2 in the granulosa cells and oocyte of most of the follicles in the ovary, suggesting that these cells have the capacity to respond to BMP signaling. Although much is known about BMP4 signaling, its expression pattern in the female reproductive tract (FRT) is still unclear. The objective of the current study was to characterize the expression of BMP4 and its downstream target proteins (pSMAD1/5/8) in the FRT. In the ovary, BMP4 protein was detected in all the stages of follicular development. Staining for pSMAD1/5/8 was observed in granulosa cells and oocytes of all the stages of follicular development including primordial follicles, suggesting that these follicles are responsive to autocrine/paracrine BMP signaling. In the uterus, BMP4 and pSMAD1/5/8 staining was observed in all three compartments and strongest expression was observed during the estrus phase. BMP4- and pSMAD1/5/8-specific staining was also observed in oviductal epithelium. Different forms (apparent MW: 50, 35, and 15 âkDa) of BMP4 were detected in mouse ovary by western blot analysis. In conclusion, these results have defined BMP4 and pSMAD1/5/8 protein expression in the mouse FRT and highlighted the importance of BMP4 in folliculogenesis.
Assuntos
Proteína Morfogenética Óssea 4/metabolismo , Ovário/metabolismo , Oviductos/metabolismo , Transdução de Sinais/fisiologia , Útero/metabolismo , Animais , Anticorpos/metabolismo , Especificidade de Anticorpos , Proteína Morfogenética Óssea 4/imunologia , Feminino , Células da Granulosa/citologia , Células da Granulosa/metabolismo , Camundongos , Modelos Animais , Oócitos/citologia , Oócitos/metabolismo , Ovário/citologia , Oviductos/citologia , Proteína Smad1/imunologia , Proteína Smad1/metabolismo , Proteína Smad5/imunologia , Proteína Smad5/metabolismo , Proteína Smad8/imunologia , Proteína Smad8/metabolismo , Útero/citologiaRESUMO
BACKGROUND: Cytokines of the transforming growth factor ß (TGF-ß) superfamily exert effects on proliferation, apoptosis and differentiation in various cell types. Cancer cells frequently acquire resistance to the anti-proliferative signals of TGF-ß, which can be due to mutations in proteins of the signalling cascade. We compared the TGF-ß-related signalling properties in B-cell lymphoma cell lines that were sensitive or resistant to TGF-ß-induced anti-proliferative effects. RESULTS: TGF-ß sensitive cell lines expressed higher cell surface levels of the activin receptor-like kinase 5 (Alk-5), a TGF-ß receptor type 1. The expression levels of the other TGF-ß and bone morphogenetic protein receptors were comparable in the different cell lines. TGF-ß-induced phosphorylation of Smad2 was similar in TGF-ß sensitive and resistant cell lines. In contrast, activation of Smad1/5 was restricted to cells that were sensitive to growth inhibition by TGF-ß. Moreover, with activin A we detected limited anti-proliferative effects, strong phosphorylation of Smad2, but no Smad1/5 phosphorylation. Up-regulation of the TGF-ß target genes Id1 and Pai-1 was identified in the TGF-ß sensitive cell lines. Constitutive phosphorylation of MAPK p38 was restricted to the TGF-ß sensitive cell lines. Inhibition of p38 MAPK led to reduced sensitivity to TGF-ß. CONCLUSIONS: We suggest that phosphorylation of Smad1/5 is important for the anti-proliferative effects of TGF-ß in B-cell lymphoma. Alk-5 was highly expressed in the sensitive cell lines, and might be important for signalling through Smad1/5. Our results indicate a role for p38 MAPK in the regulation of TGF-ß-induced anti-proliferative effects.
Assuntos
Linfócitos B/efeitos dos fármacos , Linfoma de Células B/imunologia , Proteína Smad1/metabolismo , Proteína Smad5/metabolismo , Fator de Crescimento Transformador beta/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo , Linfócitos B/imunologia , Linfócitos B/metabolismo , Linfócitos B/patologia , Receptores de Proteínas Morfogenéticas Ósseas/metabolismo , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Ativação Enzimática/efeitos dos fármacos , Inibidores do Crescimento/farmacologia , Humanos , Linfoma de Células B/tratamento farmacológico , Linfoma de Células B/patologia , Fosforilação , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , Receptor do Fator de Crescimento Transformador beta Tipo I , Receptores de Fatores de Crescimento Transformadores beta/genética , Receptores de Fatores de Crescimento Transformadores beta/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Proteína Smad1/imunologia , Proteína Smad5/imunologiaRESUMO
We report here the development of a group of rabbit monoclonal antibodies against Smad1, Smad2, Smad3, and Smad5, and the immunocytochemistry (ICC) staining of human embryonic stem cells (hESC) and mouse embryonic stem cells (mESC). Eight New Zealand rabbits were immunized with synthesized peptides linked to KLH, and splenocytes from these rabbits were fused with rabbit immortal B cell 240E-W2. Resulting hybridomas producing anti-Smad monoclonal antibodies were screened by enzyme-linked immunosorbent assay (ELISA) with BSA-linked peptides. Clones were chosen for antibody production based on their activities in Western blotting and on paraffin-embedded human tissues, and the capacity of the antibodies in immunocytochemistry was demonstrated. Using these antibodies, we performed ICC staining on routinely cultured human and mouse embryonic stem cells, and showed that both cell types strongly express these genes. We propose that both hESCs and mESCs have the ability to transduce signals from both BMPs and TGF-b/Activin.